Combining CGH and SNP assays on same microarray, creates a unique cytogenetics tool

Agilent Technologies Inc today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.

This is the only two-colour CGH platform that can detect loss of heterozygosity/uniparental disomy (LOH/UPD) with 5- to 10-megabase resolution.